Answers are grounded in this paper and cite their sources.
MXenes are conventionally produced by immersing MAX phases in fluoride-containing acids, where removal of A elements proceeds via their proton-driven oxidation leading to H 2 gas evolution accompanied by fluoride complexation with A n+ . Here we introduce a different, oxygen-driven HF vapor assisted route (OxyVap-HF) in which a precursor MAX phase, such as Ti 3 AlC 2 , is held separated from a dilute HF solution reservoir and etched by oxygen available in air, assisted by HF/H 2 O vapor helping to maintain access of oxygen to A element layers. Importantly, in OxyVap-HF the MAX phase is never in direct contact with liquid, therefore the same dilute HF solution can be used multiple times without purification or any other treatment, minimizing safety risks and environmental burden of MXene synthesis, thereby directly addressing the need for greener MXene synthesis methods. Mechanistically, in the oxygen-containing atmosphere of the OxyVap-HF the etching reaction consumes O 2 rather than evolving H 2 . Gas volume analysis, scavenging of O 2 with pyrogallol, experiments in controlled Ar/O 2 /air atmospheres, and Raman spectroscopy of the gas phase demonstrate a switch from traditional proton-driven, H 2 -evolving etching under Ar, to oxygen-driven etching in air. The HF/H 2 O ratio controls MAX phase conversion, assisting with the removal of Al–O-containing intermediates formed during etching, installing terminations, and expanding the interlayer spacing, thus yielding MXenes that can be further delaminated. We show that an aqueous HF solution with concentration as low as 3 wt% can be used repeatedly in OxyVap-HF process, consistently yielding new batches of delaminable MXenes.
No takes yet. Share an insight, caveat, or question.
Chiang et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: